1 |
Acthar high dose (80 u) |
- |
- |
- |
- |
049 1件: 49 💬 |
2 |
Administration of a high dose of desipramine |
Desipramine |
2件: D00812 D00812, D07791 D07791 💬 |
SLC6A2 2件: SLC6A2, SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
156 1件: 156 💬 |
3 |
Ambrisentan - high dose |
Ambrisentan |
1件: D07077 D07077 💬 |
EDNRA 1件: EDNRA 💬 |
Calcium signaling pathway 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 1件: 86 💬 |
4 |
Bi 655064 high dose |
- |
- |
- |
- |
046 1件: 46 💬 |
5 |
Biil 284 bs high dose |
- |
- |
- |
- |
046 1件: 46 💬 |
6 |
Biil 284 bs, high dose |
- |
- |
- |
- |
299 1件: 299 💬 |
7 |
Biil 284 bs, high dose, adult patients |
- |
- |
- |
- |
299 1件: 299 💬 |
8 |
Biil 284 bs, high dose, pediatric patients |
- |
- |
- |
- |
299 1件: 299 💬 |
9 |
Birb 796 bs, high dose |
- |
- |
- |
- |
046 1件: 46 💬 |
10 |
Bli-1300 high dose |
- |
- |
- |
- |
096 1件: 96 💬 |
11 |
Brazikumab high dose |
Brazikumab |
1件: D10912 D10912 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 1件: 96 💬 |
12 |
Clobazam high dose |
Clobazam |
1件: D01253 D01253 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
144 1件: 144 💬 |
13 |
Cvn424 high dose |
- |
- |
- |
- |
006 1件: 6 💬 |
14 |
Cvt-301 high dose |
- |
- |
- |
- |
006 1件: 6 💬 |
15 |
Dns-7801 (high dose) |
- |
- |
- |
- |
006 1件: 6 💬 |
16 |
Elamipretide (high dose) |
Elamipretide |
1件: D10925 D10925 💬 |
- |
- |
021 1件: 21 💬 |
17 |
Eur-1008 (apt-1008) high dose |
- |
- |
- |
- |
298 1件: 298 💬 |
18 |
Fentanyl (high dose) |
Fentanyl |
2件: D00320 D00320, D01399 D01399 💬 |
OPRM1 1件: OPRM1 💬 |
Estrogen signaling pathway 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
215 1件: 215 💬 |
19 |
High dose |
- |
- |
- |
- |
097 1件: 97 💬 |
20 |
High dose affitope® pd03a + adjuvant |
- |
- |
- |
- |
006 1件: 6 💬 |
21 |
High dose anavex2-73 |
- |
- |
- |
- |
006 1件: 6 💬 |
22 |
High dose aspirin (1300 mg/day) |
Acetylsalicylic acid |
1件: D00109 D00109 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 1件: 13 💬 |
23 |
High dose bibf 1120 twice daily |
- |
- |
- |
- |
085 1件: 85 💬 |
24 |
High dose budesonide |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
25 |
High dose budesonide suspension |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
098 1件: 98 💬 |
26 |
High dose budesonide tablet |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
098 1件: 98 💬 |
27 |
High dose dexamethasone pulses |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
063 1件: 63 💬 |
28 |
High dose lactulose |
Lactulose |
1件: D00352 D00352 💬 |
- |
- |
291 1件: 291 💬 |
29 |
High dose mesenchymal stem cells (mscs) |
- |
- |
- |
- |
049 1件: 49 💬 |
30 |
High dose of biil 284 bs tablets |
- |
- |
- |
- |
046 1件: 46 💬 |
31 |
High dose of budesonide |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
299 1件: 299 💬 |
32 |
High dose ortd-1 |
- |
- |
- |
- |
046 1件: 46 💬 |
33 |
High dose tso |
- |
- |
- |
- |
096 1件: 96 💬 |
34 |
High dose vehicle control |
- |
- |
- |
- |
046 1件: 46 💬 |
35 |
High dose-vis649 |
- |
- |
- |
- |
066 1件: 66 💬 |
36 |
High doses of thiamine y biotin |
Biotin |
2件: D00029 D00029, D08580 D08580 💬 |
- |
- |
008 1件: 8 💬 |
37 |
Hmpl-004 high dose |
- |
- |
- |
- |
097 1件: 97 💬 |
38 |
Igpro20 (high dose) |
- |
- |
- |
- |
014 1件: 14 💬 |
39 |
Kps-0373, high dose |
- |
- |
- |
- |
018 1件: 18 💬 |
40 |
Kw-6356 high dose |
- |
- |
- |
- |
006 1件: 6 💬 |
41 |
Liris low dose and liris high dose |
- |
- |
- |
- |
226 1件: 226 💬 |
42 |
Lx3305 high dose |
- |
- |
- |
- |
046 1件: 46 💬 |
43 |
Medi7183 high dose |
- |
- |
- |
- |
097 1件: 97 💬 |
44 |
Mmx mesalamine/mesalazine (high dose) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
45 |
Mt-1303 high dose |
- |
- |
- |
- |
049 1件: 49 💬 |
46 |
Mt-7117 high dose |
- |
- |
- |
- |
254 1件: 254 💬 |
47 |
Multistem high dose |
MultiStem |
- |
- |
- |
097 1件: 97 💬 |
48 |
Pf-06649751 high dose (15 mg qd) |
Tavapadon |
1件: D11431 D11431 💬 |
DRD1 2件: DRD1, DRD5 💬 |
Alcoholism 10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway |
006 1件: 6 💬 |
49 |
Procedure: non-myeloablative high dose immunosuppressive therapy conditioning (hdit) |
- |
- |
- |
- |
049 1件: 49 💬 |
50 |
Pxt3003 high dose |
- |
- |
- |
- |
010 1件: 10 💬 |
51 |
Ravicti high dose |
- |
- |
- |
- |
299 1件: 299 💬 |
52 |
Sen0014196 (high dose) |
- |
- |
- |
- |
008 1件: 8 💬 |
53 |
Tas5315 high dose |
- |
- |
- |
- |
046 1件: 46 💬 |
54 |
Vitamin d3 - high dose |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
006 1件: 6 💬 |
55 |
Yra-1909 high dose |
- |
- |
- |
- |
046 1件: 46 💬 |